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Abstract
Background: Mast cells reside within the connective tissue of a variety of tissues and all vascularized organs. Since 1996,
few studies have been performed on mast cell density in gastrointestinal biopsies, mainly in adult age group. We recently
studied mast cell density in pediatric age group on rather larger number of cases in a referral children hospital. Mast cell
density was 12.6 ± 0.87 in 0.25 mm2 (range: 0-81) in our study.
Since we frequently encounter cases with rather normal gastric biopsies with no H.pylori, which mainly complain of
chronic abdominal pain, we gathered those cases with mast cell density more than 30/0.25 mm2. from 895 gastric biopsies
and wanted to study their clinical and endoscopic findings and propose a new entity.
Methods: Between April 2005 and May 2008, 895 children (< 14 years old), with gastrointestinal complaints who
underwent endoscopy were selected and antral biopsies were obtained for histological examination. Among these
children, those who had normal or erythematous (but not nodular or ulcerative) gastric mucosa on endoscopic view,
plus pathologic report of normal mucosa or mild gastritis in addition to mast cell count more than 30/25 mm2, were
chosen and a questionnaire was filled for each patient including clinical, endoscopic and pathologic findings.
The statistical analysis was performed using SPSS, version 13 (SPSS Inc., Chicago, IL, USA).
Results: Over a 3 year period of study, of 895 selected children, 86 patients fulfilled the entrance criteria. The major
complaint of patients was recurrent abdominal pain. The mean mast cell density was 45.59 ± 13.81 in 0.25 mm2 (range:
30-93). Among our cases, about 67.4% (n = 58) had 30 to 49, 23.3% (n = 20) had 50 to 69, 8.1% (n = 7) had 70 to 89 and
1.2% (n = 1) had 93 mast cells/0.25 mm2 in their specimens
Discussion: In 29% of our cases, neither endoscopic nor pathologic change was detected and only increase in mast cell
number was reported and in others endoscopic and histopathological findings were negligible except increase in mast
cells. In updated Sydney system (classification and grading of gastritis), no term is introduced which is in concordance
with this group but we think that increased density of mast cells in these cases should not be overlooked and it may
contribute to clinical manifestations in some way. We hope that further studies will direct us to institute therapeutic
measurements in this regard.
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Introduction
Mast cells are round, generally mononuclear cells, which
exhibit phenotypic variation in morphology. Cell diame-
ter ranges up to 25 μm. Nucleus is unilobed and may be
round or oval in shape and is typically eccentrically posi-
tioned. Electron microscopy shows numerous cytoplas-
mic projections that may interdigitate with other cells [1].
Mast cell can be recognized by its numerous metachro-
matic cytoplasmic granules, which range in size from 0.3
to 0.8 μm and which may occupy the majority of the cell
volume [1]. These granules stain red-purple with the basic
dye toluidine blue or Giemsa (figure 1). This property of
staining red upon application of a blue dye is referred to
as metachromatic staining and is due to the presence of
highly sulfated, anionic proteoglycans complexed with
the various secretory granule proteases, a property that is
shared by basophils. Poorly granulated mast cells or mast
cells that have recently degranulated extensively, if stained
with Giemsa or toluidine blue, can be mistaken for eosi-
nophils or histiocytes, a detail that can complicate the
diagnosis of mast cell related disorders [1-7].
Mast cells reside within the connective tissue of a variety
of tissues and all vascularized organs. Their numbers and
densities are highest at interfaces between the internal and
external environments where they can respond to foreign
organisms and antigens [1]. Sites include the dermis, gut
mucosa and submucosa, conjunctiva, pulmonary alveoli
and airways, and the atrial appendage of the heart [1-7].
Since 1996, few studies have been performed on mast cell
density in gastrointestinal biopsies, mainly in adult age
group. Sulik et al. studied mast cell involvement in chil-
dren with or without infection by Helicobacter pylori
(H.pylori). Results of this study showed that mast cell
through its numerous mediators may play a key role in
chronic gastritis especially in H. pylori positive cases [8].
Mysorekar et al have reported that mast cell counts were
significantly higher in the antral mucosa in gastritis [9].
Nakajima et al demonstrated the presence of mast cells by
immunohistochemical staining with anti human tryptase
antibody in gastric biopsies and concluded that mast cells
may be important effector cells in the pathogenesis of gas-
tritis [10]. Fazilet Kayaselcuk et al investigated the rela-
tionship between mast cell density, H. pylori density and
histopathological severity of gastritis in the corpus and
antral mucosa and concluded that the difference between
the mast cell density in the antrum and that in the corpus
was significant for all three variables [11]. N. Moorchung
et el attempted to study the relationship between endos-
copy and the mast cell and eosinophil infiltrate and also
studied the role of gene polymorphisms, Helicobacter
pylori density and the CagA antibody status in influencing
the mast cell and eosinophil infiltrate, but in contrast to
other studies, mast cells did not have a significant role in
their study [12].
As mentioned above, studies on mast cell density have
been performed mainly on adults and on rather small
groups as yet. We recently studied mast cell density in
pediatric age group on rather larger number of cases in a
referral children hospital with longstanding experience in
pediatric gastroenterology [13]. Mast cell density was 12.6
± 0.87 in 0.25 mm2 (range: 0-81) in our study.
We found no significant correlation between mast cell
density and sex of patients. Also no significant correlation
was found between mast cell density and presence and
degree of inflammation, activity and presence of H. pylori
[13]. However we proposed that maybe mast cells play a
role in producing clinical symptoms not by their tradi-
tional known pathways in inflammatory processes but by
an as yet undefined pathway such as stimulatory effect on
gastric nerve plexuses. So we recommended that increase
in mast cell density should be included in the final report
of gastric biopsies [13].
We frequently encounter cases with rather normal gastric
biopsies or only mild chronic inflammation with no
H.pylori, which mainly complain of chronic abdominal
pain. We gathered these cases with mast cell density more
than 30/0.25 mm2 from 895 gastric biopsies and wanted
to study their clinical and endoscopic findings and pro-
pose a new entity.
Mast cells are stained by Giemsa staining and are seen best  by oil (×1000), in this case five mast cells are seen in this high  power field Figure 1
Mast cells are stained by Giemsa staining and are 
seen best by oil (×1000), in this case five mast cells 
are seen in this high power field.Diagnostic Pathology 2009, 4:34 http://www.diagnosticpathology.org/content/4/1/34
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Materials and methods
Between April 2005 and May 2008, 895 children (< 14
years old), with gastrointestinal complaints who under-
went endoscopy were selected and antral biopsies were
obtained for histological examination at Children Medi-
cal Center (children hospital affiliated with Tehran Uni-
versity of Medical Sciences). The specimens were fixed in
10% buffered formalin, processed, embedded in paraffin
and cut in sequential 3 micrometer sections. Superficial
and deep sections were stained by Hematoxylin-eosin
(two slides) and one slide was stained by Giemsa stain.
Mast cells were counted by Giemsa stain at ×1000 magni-
fication in 10 fields with a Zeiss standard 20 light micro-
scope and the sum was calculated for each case
(measuring 0.25 mm2). All the mast cell counts and histo-
logical evaluation was performed by a single observer (F.
Mahjoub).
Among these children, those who had normal or ery-
thematous (but not nodular or ulcerative) gastric mucosa
on endoscopic view, plus pathologic report of normal
mucosa or mild gastritis in addition to mast cell count
more than 30/25 mm2, were chosen and a questionnaire
was filled for each patient including clinical, endoscopic
and pathologic findings.
The statistical analysis was performed using SPSS, version
13 (SPSS Inc., Chicago, IL, USA).
Results
Over a 3 year period of study, of 895 selected children, 86
patients fulfilled the entrance criteria. Among these
patients, 55.8% (48 persons) were male. There was no sig-
nificant difference between sex of patients (p > 0.05). The
mean age of patients included in the study was 6.68 ± 3.06
(range: 1-14 years). Table 1 provides a summary of
patients' clinical manifestations. As shown in table 1,
most common clinical manifestations were recurrent
abdominal pain (n = 59 (68.6%)) and vomiting (n = 34
(39.5%)). No significant relation was found between sex
and type of gastrointestinal complaints (p > 0.05). Endo-
scopic and pathologic findings are shown in table 2. Non
of our patients had signs of systemic mastocytosis.
Mast cell density was divided in four categories: [30-49],
[50-69], [70-89] and [90-110]. The mean mast cell density
was 45.59 ± 13.81 in 0.25 mm2 (range: 30-93). Among
our cases, about 67.4% (n = 58) had 30 to 49, 23.3% (n =
20) had 50 to 69, 8.1% (n = 7) had 70 to 89 and 1.2% (n
= 1) had 93 mast cells/0.25 mm2 in their specimens (fig-
ure 2). No significant relation was found between clinical
and endoscopic findings and mast cell density (p > 0.05)
(figure 3).
As shown in table 3, of 86 cases, 61.6% of gastric biopsies
showed no significant pathologic change, 33.7% mild
Table 1: Frequency of clinical manifestations
Clinical manifestation  Frequency %
Recurrent abdominal pain 59 68.6
Vomiting 34 39.5
Low weight gain 17 19.8
Gastrointestinal bleeding
Hematemesis 7 8.1
Bloody stool 3 3.5
Gastro esophageal reflux disorder 6 7
Heart burn 2 2.3
Diarrhea 2 2.3
Anemia 2 2.3
Chronic renal failure 2 2.3
Others 4 4.7
Total 86 100
Table 2: The relationship between endoscopic and pathologic findings
Gastric pathology Total
Normal Mild gastritis Decrease in glands' number and fibrosis
Gastric endoscopy Normal gastric mucosa 25
(29.1%)
11
(12.8%)
3
(3.5%)
39
(45.3%)
Diffuse erythema 10
(11.6%)
7
(8.1%)
1
(1.2%)
18
(21%)
Patchy erythema 15
(17.4%)
11
(12.8%)
0
(0%)
26
(30.2%)
Localized fundal erythema 1
(1.2%)
0
(0%)
0
(0%)
1
(1.2%)
Missing 1
(1.2%)
0
(0%)
0
(0%)
1
(1.2%)
Edematous gastric mucosa 1
(1.2%)
0
(0%)
0
(0%)
1
(1.2%)
Total 53
(61.6%)
29
(33.7%)
4
(4.7%)
86
(100%)Diagnostic Pathology 2009, 4:34 http://www.diagnosticpathology.org/content/4/1/34
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chronic gastritis and 4.7% decrease in glands' number and
fibrosis.
Discussion
Results of some studies suggested that mast cells play a
role in the inflammatory reaction in the course of gastritis.
There is only little data in literature concerning the
number and role of mast cells in children with gasteroin-
testinal complaints and existing data have rather conflict-
ing results.
Mast cell detection is rather easy by a simple and inexpen-
sive staining (Giemsa) which can also be used to detect
presence of H. pylori. It is of worth nothing that reliable
detection is achieved by examining the tissue under oil
immersion (×1000) and in lower magnifications they can
be missed. Although the gold standard is staining of tissue
with anti-tryptase antibody by immunohistochemical
methods, it is a time consuming and rather expensive
method and is not recommended for routine pathologic
assessment of gastric biopsies [13].
In this study, we evaluated biopsy specimens of gastric
mucosa collected from pediatric patients in a referral chil-
dren hospital with longstanding experience in pediatric
gastroenterology who had normal histology except
increase in mast cells.
The mean mast cell density of our cases was 45.59 ± 13.81
in 0.25 mm2(range: 30-93).
In 29% of our cases, neither endoscopic nor pathologic
change was detected and only increase in mast cell
number was reported and in others endoscopic and his-
topathological findings were negligible except increase in
mast cells. In updated Sydney system (classification and
grading of gastritis) [14], no term is introduced which is
Table 3: Mast cell density and pathological findings
Gastric pathology Total
Normal Mild gastritis Decrease in glands' number and fibrosis
Mast 30-49 36 18 4 58
Cell 50-69 13 7 0 20
Density 70-89 4 3 0 7
90-110 0 1 0 1
Total 53 29 4 86
Distribution of mast cell density Figure 2
Distribution of mast cell density.
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Box plot of mast cell density and gastric endoscopy.
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in concordance with this group. We propose that maybe
mast cells play a role in producing such symptoms not by
their traditional known pathways in inflammatory proc-
esses but by an as yet undefined pathway such as stimula-
tory effect on gastric nerve plexuses [13]. Mast cell count
is not routinely performed in gastric biopsies, however
rough estimate of mast cell density can be done in Giemsa
stained slides. We recommend that mast cell density
should be included in the final report of gastric biopsies.
We also propose the term "mast cell gastritis" as a new and
different term to be included in classification and grading
of gastritis, in cases with normal histology but mast cell
count above 30/25 mm2.
We think that increased density of mast cells in these cases
should not be overlooked and it may contribute to clinical
manifestations in some way. We hope that further studies
will direct us to institute therapeutic measurements in this
regard.
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